Intraepithelial cytotoxic T-cells (usually defined as CD8+) recognize cancer-specific antigens carried by presenting cells and generate local inflammation via cytokine release, particularly interferon-gamma (IFNγ) and tumor necrosis factor alpha (TNFα) and recruitment of secondary immune actors that lead to the elimination of tumor cells (Figure 1). This evidence concerns the gene CD8A and cancer.